Pharmaceutical strategy - Timeline

Vastuvõetud arvamused on 27/04/2021 - Bureau decision date: 01/12/2020
Viide: 
INT/926-EESC-2020-5886
Opinion Type: 
vabatahtliku konsulteerimise taotlus
Referral: 
COM(2020) 761 final
Official Journal: 
OJ C 286, 16.7.2021, p. 53
Rapporteur: 
Martin SCHAFFENRATH (Diversity Europe - GR III / Austria)
27Apr2021
Ravimistrateegia
Type:
Committee opinion (AC)

Ravimistrateegia

Ravimistrateegia
Type:
Section opinion (AS)

Ravimistrateegia

Ravimistrateegia
Type:
Information memo for a new referral (NINS)

Ravimistrateegia

Jälgi menetluskäiku: 2020/0343/COD

/

Allkiri

Esimene lugemine

Arvamused

Ettepanek